BSX - Boston Sci issues corrective recall for Obsidio Embolic over safety concerns
2024-04-17 16:15:11 ET
More on Boston Scientific
- Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
- Boston Scientific: The Market's Newest Mega-Cap Needs A Breather
- Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript
- Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
- Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal